Zenas BioPharma (ZBIO) Change in Cash (2023 - 2026)

Zenas BioPharma's Change in Cash history runs 4 years deep, the most recent figure standing at $389.6 million for Q1 2026.

• On a quarterly basis, Change in Cash rose 416.02% year-over-year to $389.6 million in Q1 2026; TTM through Mar 2026 was $303.7 million, a 90.61% increase from a year earlier, with the FY2025 full-year figure at -$209.2 million, down 179.57% from the prior year.
• Change in Cash improved to $389.6 million in Q1 2026 per ZBIO's latest filing, from -$4.9 million in the prior quarter.
• Across five years, Change in Cash topped out at $389.6 million in Q1 2026 and bottomed at -$152.5 million in Q2 2025.
• The 4-year median for Change in Cash is -$10.2 million (2023), against an average of $42.8 million.
• Across the five-year window, Change in Cash sank 525.71% in 2025 and surged 416.02% in 2026, its largest moves.
• Year by year, Change in Cash stood at -$15.5 million in 2023, then slumped by 160.74% to -$40.3 million in 2024, then soared by 87.78% to -$4.9 million in 2025, then surged by 8011.92% to $389.6 million in 2026.
• Per Business Quant, the three latest ZBIO Change in Cash figures stand at $389.6 million (Q1 2026), -$4.9 million (Q4 2025), and $71.6 million (Q3 2025).